Metastatic Renal Cell Carcinoma: Sunitinib as First-Line Treatment; Results of a Retrospective Study

Pubblicato online: 31 mar 2016

Pagine: 23 - 27

Ricevuto: 30 ago 2015

Accettato: 15 dic 2015

DOI: https://doi.org/10.1515/fco-2015-0017

Parole chiave

Sunitinib, Metastasis, Renal Cell Carcinoma, Targeted agents

© 2015 Hend Ahmed El-Hadaad et al., published by De Gruyter Open

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.